Fortress Biotech Stock Price

-0.06 (-1.63%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Fortress Biotech Inc FBIO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.06 -1.63% 3.62 20:00:00
Open Price Low Price High Price Close Price Prev Close
3.69 3.4901 3.78 3.61 3.68
Bid Price Ask Price Spread News
3.58 3.81 0.23 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5,686 774,667 $ 3.63 $ 2,808,641 2,790,967 2.12 - 6.10
Last Trade Time Type Quantity Stock Price Currency
19:18:31 6 $ 3.61 USD

Fortress Biotech Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 352.06M 97.25M 72.42M $ 45.60M $ - -0.64 -5.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 2.53M 27.40%

more financials information »

Fortress Biotech News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical FBIO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.064.0913.49013.81826,355-0.44-10.84%
1 Month4.364.793.49014.171,103,519-0.74-16.97%
3 Months4.,996,717-0.54-12.98%
6 Months2.526.102.364.261,368,5731.1043.65%
1 Year2.466.102.123.811,273,4401.1647.15%
3 Years3.546.100.493.01709,3510.082.26%
5 Years2.806.100.493.10489,1480.8229.29%

Fortress Biotech Description

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

Your Recent History
Fortress B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.